Halozyme Therapeutics Inc. Common Stock vs Vodafone Group Plc American Depositary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Vodafone Group Plc American Depositary Shares trades at $15.56 (market cap $38.08B). The key difference: Vodafone Group Plc American Depositary Shares is far larger — about 3× Halozyme Therapeutics Inc. Common Stock's market cap, and Vodafone Group Plc American Depositary Shares pays a 3.26% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Vodafone Group Plc American Depositary Shares for 0 Days on average.
| HALO | VOD | |
|---|---|---|
Market Cap | $12.58B | $38.08B |
Volume | 2,179,278 | 3,820,235 |
Sector | Health | Media |
52-Week High | $115.22 | $17.68 |
52-Week Low | $61.63 | $11.17 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $14.49B | $83.23B |
Dividend Yield | — | 3.26% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Vodafone provides mobile, fixed-line, broadband, and business communications services. It operates across Europe and Africa.
Read more on VOD →